Related references
Note: Only part of the references are listed.Anti-Ferroptosis Drug Enhances Total-Body Irradiation Mitigation by Drugs that Block Apoptosis and Necroptosis
Stephanie Thermozier et al.
RADIATION RESEARCH (2020)
Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer
Yong Mei et al.
DNA AND CELL BIOLOGY (2020)
Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis
Chunyan Luan et al.
ONCOTARGETS AND THERAPY (2020)
Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p
Ke Li et al.
THORACIC CANCER (2020)
M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
Hong Xiao et al.
ACS CENTRAL SCIENCE (2020)
Ferroptosis and Cancer: Mitochondria Meet the Iron Maiden Cell Death
Anna Martina Battaglia et al.
CELLS (2020)
Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4
Cong Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis
Zhiqiang Wu et al.
MOLECULAR ONCOLOGY (2019)
Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
Ruomi Guo et al.
ADVANCED SCIENCE (2019)
Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis
Ming-Jun Fan et al.
BIOSCIENCE REPORTS (2019)
MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer
Wei Wei et al.
GENE (2019)
Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects
Pawel Wiczling et al.
PLOS ONE (2019)
Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis
Xin Chen et al.
CELL BIOLOGY INTERNATIONAL (2019)
Erastin Inhibits Septic Shock and Inflammatory Gene Expression via Suppression of the NF-κB Pathway
Byung Moo Oh et al.
JOURNAL OF CLINICAL MEDICINE (2019)
CRISPR/Cas9 Mediated GFP Knock-in at the MAP1LC3B Locus in 293FT Cells Is Better for Bona Fide Monitoring Cellular Autophagy
Zhiqiang Wu et al.
BIOTECHNOLOGY JOURNAL (2018)
miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin
Wang Xie et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals
Jing Liu et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
CRISPR/Cas9 Mediated GFP Knock-in at the MAP1LC3B Locus in 293FT Cells Is Better for Bona Fide Monitoring Cellular Autophagy
Zhiqiang Wu et al.
BIOTECHNOLOGY JOURNAL (2018)
LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma
Shaoying Yan et al.
GENE (2018)
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance
Maria Luisa Gasparri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
Haihai Liang et al.
MOLECULAR CANCER (2018)
Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
Yu Guo et al.
NATURE COMMUNICATIONS (2018)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhuxian Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma
Tong Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Theranostical Nanosystem-Mediated Identification of an Oncogene and Highly Effective Therapy in Hepatocellular Carcinoma
Yu Guo et al.
HEPATOLOGY (2016)
Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma
Yu Guo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Annexin A2 knockdown inhibits hepatoma tell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression
Chong Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer
J. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
Leibo Xu et al.
JOURNAL OF HEPATOLOGY (2014)
miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells
Yonghua Xu et al.
ONCOLOGY REPORTS (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem
Yu Guo et al.
ACS NANO (2012)
Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63
Y. F. Wu et al.
NEOPLASMA (2010)
Share Paper
